| |
| |
|
| Insider
Information: |
Hecht Beth |
| Relationship: |
Director |
| City: |
Grand Prairie |
| State: |
TX |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
27,891 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$58,957 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
27,891 |
|
|
| Total
Value |
$58,957 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
2
|
0
|
|
Stock
price went up :
|
2
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
2.0
|
0.0
|
| Percentage
Gain/Loss : |
 59.5%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Xeris Pharmaceuticals Inc |
XERS |
See Remarks |
2021-10-05 |
0 |
2019-02-19 |
0 |
Premium* |
|
|
Neos Therapeutics, Inc. |
NEOS |
Director |
2021-03-19 |
0 |
2020-06-10 |
0 |
Premium* |
|
|
AYTU BIOSCIENCE, INC |
AYTU |
Director |
2021-04-08 |
9,052 |
|
0 |
Premium* |
|
|
Iterum Therapeutics Plc |
ITRM |
Director |
2023-06-15 |
18,839 |
2022-03-18 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
16 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ITRM |
Iterum Therapeutics Plc |
Director |
– • – |
2023-06-15 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,853 |
18,839 |
0 |
- |
|
| ITRM |
Iterum Therapeutics Plc |
Director |
– • – |
2022-06-23 |
4 |
OE |
$0.00 |
$0 |
D/D |
36,798 |
44,805 |
0 |
- |
|
| ITRM |
Iterum Therapeutics Plc |
Director |
– • – |
2022-03-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,642 |
8,007 |
0 |
- |
|
| XERS |
Xeris Pharmaceuticals Inc |
See Remarks |
• – – |
2021-10-05 |
4 |
D |
$0.00 |
$0 |
D/D |
(206,366) |
0 |
0 |
- |
|
| AYTU |
AYTU BIOSCIENCE, INC |
Director |
– • – |
2021-04-08 |
4 |
A |
$0.00 |
$0 |
D/D |
6,500 |
9,052 |
0 |
- |
|
| AYTU |
AYTU BIOSCIENCE, INC |
Director |
– • – |
2021-03-19 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
2,552 |
|
% |
|
| NEOS |
Neos Therapeutics, Inc. |
Director |
– • – |
2021-03-19 |
4 |
D |
$0.00 |
$0 |
D/D |
(23,453) |
0 |
0 |
- |
|
| XERS |
Xeris Pharmaceuticals Inc |
See Remarks |
• – – |
2021-01-29 |
4 |
A |
$0.00 |
$0 |
D/D |
150,000 |
210,814 |
0 |
- |
|
| XERS |
Xeris Pharmaceuticals Inc |
See Remarks |
• – – |
2020-06-30 |
4 |
A |
$2.26 |
$8,432 |
D/D |
3,731 |
60,814 |
0 |
- |
|
| NEOS |
Neos Therapeutics, Inc. |
Director |
– • – |
2020-06-10 |
4 |
A |
$0.00 |
$0 |
D/D |
23,453 |
23,453 |
0 |
- |
|
| XERS |
Xeris Pharmaceuticals Inc |
See Remarks |
• – – |
2020-03-13 |
4 |
B |
$1.97 |
$7,880 |
D/D |
4,000 |
57,083 |
2.74 |
% |
|
| XERS |
Xeris Pharmaceuticals Inc |
See Remarks |
• – – |
2020-02-14 |
4 |
B |
$4.15 |
$16,600 |
D/D |
4,000 |
8,083 |
2.74 |
% |
|
| XERS |
Xeris Pharmaceuticals Inc |
See Remarks |
• – – |
2020-01-31 |
4 |
A |
$0.00 |
$0 |
D/D |
45,000 |
53,083 |
0 |
- |
|
| XERS |
Xeris Pharmaceuticals Inc |
See Remarks |
• – – |
2019-12-31 |
4 |
A |
$5.99 |
$2,749 |
D/D |
459 |
4,083 |
0 |
- |
|
| XERS |
Xeris Pharmaceuticals Inc |
See Remarks |
• – – |
2019-07-01 |
4 |
A |
$9.72 |
$10,925 |
D/D |
1,124 |
3,928 |
0 |
- |
|
| XERS |
Xeris Pharmaceuticals Inc |
See Remarks |
• – – |
2019-02-19 |
4 |
B |
$10.00 |
$25,000 |
D/D |
2,500 |
2,500 |
2.74 |
- |
|
16 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
